Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats

British Journal of Nutrition

Volumn 101, Issue 7, 2009, Pages 1031-1039

  Lim, Sun Hye ^a   Ha, Tae Youl ^a   Kim, Sung Ran ^a   Ahn, Jiyun ^a   Park, Hyun Jin ^b   Kim, Suna ^a  

^a Korea Food Research Institute   (South Korea)

^b Korea University   (South Korea)

Author keywords

Bakuchiol; Bone loss; Ovariectomy; Psoralea corylifolia

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; BAKUCHIOL; CALCIUM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PHOSPHORUS; PSORALEA CORYLIFOLIA EXTRACT; ESTROGEN RECEPTOR; PHENOL DERIVATIVE; PLANT EXTRACT;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BODY WEIGHT; BONE ATROPHY; BONE DENSITY; CALCIUM BLOOD LEVEL; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DOSE COMPARISON; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; FEMALE; FOOD INTAKE; IN VITRO STUDY; LIVER; NONHUMAN; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; RAT; SOLVENT EXTRACTION; SPRAGUE DAWLEY RAT; UTERUS; UTERUS WEIGHT; WEIGHT GAIN; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; HISTOLOGY; METABOLISM; METHODOLOGY; ORGAN SIZE; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; PLANT SEED; PROTEIN BINDING; PSORALEA;

ANIMALIA; CULLEN CORYLIFOLIA; RATTUS;

ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; CALCIUM; ESTRADIOL; FEMALE; MODELS, ANIMAL; ORGAN SIZE; OSTEOPOROSIS; OVARIECTOMY; PHENOLS; PHOSPHORUS; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN BINDING; PSORALEA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; SEEDS; UTERUS; WEIGHT GAIN;

EID: 67449097760     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508066750     Document Type: Article

References (42)

1. Pike MC, Pearce CL & Wu AH (2004) Prevention of cancers of the breast, endometrium and ovary. Oncogene 23, 6379-6391.
2. Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88, 2404-2411.
3. Quereda F, Mendoza N, Olalla MA, Baro F & Duran M (2005) Prophylactic approach for asymptomatic post-menopausal women: Osteroporosis. Maturitas 15, S38-S45.
4. Ito K (2007) Hormone replacement therapy and cancers: The biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast. Tohoku J Exp Med 212, 1-12.
5. Yadava RN & Verma YA (2005) A new biologically active flavonol glycoside from Psoralea corylifolia (Linn.). J Asian Nat Prod Res 7 671-675.
6. Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, Takeda K, Yamada K & Ishimi Y (2004) Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr 134, 2623-2627.
7. Rachon D, Vortherms T, Seidlova-Wuttke D & Wuttke W (2007) Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause 22, 1-8.
8. Mathey J, Mardon J, Fokialakis N, et al. (2007) Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: The case for equol. Osteoporos Int 18, 671-679.
9. Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergstrom R, Lindgren A, Correia N & Persson I (1999) Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 91, 1131-1137.
10. Miura H, Nishida H & Iinuma M (1996) Effect of crude fractions of Psoralea corylifolia seed extract on bone calcification. Planta Med 62, 150-153.
11. Haraguchi H, Inoue J, Tamura Y & Mizutani K (2002) Antioxidative components of Psoralea corylifolia (Leguminosae). Phytother Res 16, 539-544.
12. Karsura H, Tsukiyama RI, Suzuki A & Kobayashi M (2001) In vitro antimicrobial activities of bakuchiol against oral microorganisms. Antimicrob Agents Chemother 45, 3009-3013.
13. Ferrándiz ML, Gil B, Sanz MJ, Ubeda A, Erazo S, González E, Negrete R, Pacheco S, Payá M & Alcaraz MJ (1996) Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice. J Pharm Pharmacol 48, 975-980.
14. Zhang CZ, Wang SX, Zhang Y, Chen JP & Liang XM (2005) In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. J Ethnopharmacol 98, 295-300.
15. Wang D, Li F & Jiang Z (2001) Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med 67, 748-749.
16. Singleton VL & Rossi JA (1965) Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 16, 144-158.
17. Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ & McDonnell DP (1997) Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxidol Apply Pharmacol 143, 205-212.
18. Soto A, Sonnenschein C, Chung KL, Fernandez MF, Olea N & Serrano FO (1995) The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ Health Pers 103 113-122.
19. Anderson JJ, Anthony MS, Cline JM, Washburn SA & Garner SC (1999) Health potential of soy isoflavones for menopausal women. Public Health Nutr 2, 489-504.
20. Messina MJ & Loprinzi CL (2001) Soy for breast cancer survivors: A critical review of the literature. J Nutr 131, Suppl. 11, 3095S-3108S.
21. Liu J, Buredette J, Xu H, et al. (2001) Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49, 2472-2479.
22. Kroneberg F & Fugh-Berman A (2002) Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann Intern Med 137, 805-813.
23. Dog TL, Powell KL & Weisman SM (2003) Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 10, 299-313.
24. Mishima S, Suzuki KM, Isohama Y, Kuratsu N, Araki Y, Inoue M & Miyata T (2005) Royal jelly has estrogenic effects in vitro and in vivo. J Ethnopharmacol 101, 215-220.
25. Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C & Sauer MJ (1997) Evaluation of a recombinant yeast cell estrogen screening assay. Environ Health Perspect 105, 734-742.
26. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL & Leitman DC (2004) Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64, 423-428.
27. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J & Gustafsson JA (2004) Proc Natl Acad Sci U S A 101, 1566-1571.
28. Hertrampf T, Gruca MJ, Seibel J, Laudenbach U, Fritzemeier KH & Diel P (2007) The bone-protective effect of the phytoestrogen genistein is mediated via ER α-dependent mechanisms and strongly enhanced by physical activity. Bone 40, 1529-1535.
29. Szkudelska K & Nogowski L (2007) Genistein-A dietary compound inducing hormonal and metabolic changes. J Steroid Biochem Mol Biol 17 1-9.
30. Anderson JJB, Ambrose WW & Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized lactating rat model. Proc Soc Exp Biol Med 217, 345-350.
31. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D & Malluche HH (1998) The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8, 274-281.
32. Richter CP & Uhlenhuth EH (1954) Comparison of the effects of gonadectomy of spontaneous activity of wild and domesticated Norway rats. Endocrinology 54, 311-322.
33. Tchernof A, Calles-Escandon J, Sites CK & Poehlman ET (1998) Menopause, central body fatness, and insulin resistance: Effects of hormone-replacement therapy. Coron Artery Dis 9, 503-511.
34. Mehmood Z, Smith AG, Tucker MJ, Chuzel F & Carmichael NG (2000) The development of methods for assessing the in vivo oestrogen-like effects of xenobiotics in CD-1 mice. Food Chem Toxicol 38, 493-501.
35. Picherit C, Dalle M, Neliat G, Lebecgue P, Davicco MJ, Barlet JP & Coxam V (2000) Genistein and daidzein modulate in vitro rat uterine contractile activity. J Steroid Biochem Mol Biol 75, 201-208.
36. Santell RC, Chang YC, Nair MG & Helferich WG (1997) Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 127, 263-269.
37. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW & Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72, 844-852.
38. Power KA, Ward WE, Chen JM, Saarinen NM & Thompson LU (2006) Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model. Bone 39, 117-124.
39. Squadrito F, Altavilla D, Squadrito G, et al. (2002) Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 45 454-462.
40. Mori-Okamoto J, Otawara-Hamamoto Y, Yamato H & Yoshimura M (2004) Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice. J Ethnopharmacol 92, 93-101.
41. Wood CE, Register TC, Anthony MS, Kock ND & Cline JM (2004) Breast and uterine effects of soy isoflavones and conjugated equine estrogens in postmenopausal female monkeys. J Clin Endocrinol Metab 89, 3462-3468.
42. Xiong Z, Wang D, Xu Y & Li F (2003) Osteoblastic differentiation bioassay and its application to investigating the activity of fractions and compounds from Psoralea corylifolia L. Pharmazie 58 925-928.